MRVI
Maravai LifeSciences Holdings Inc
Price:  
5.66 
USD
Volume:  
1,232,242.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRVI WACC - Weighted Average Cost of Capital

The WACC of Maravai LifeSciences Holdings Inc (MRVI) is 8.7%.

The Cost of Equity of Maravai LifeSciences Holdings Inc (MRVI) is 10.50%.
The Cost of Debt of Maravai LifeSciences Holdings Inc (MRVI) is 5.30%.

Range Selected
Cost of equity 8.90% - 12.10% 10.50%
Tax rate 11.40% - 11.70% 11.55%
Cost of debt 4.50% - 6.10% 5.30%
WACC 7.4% - 10.1% 8.7%
WACC

MRVI WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.1 1.3
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.90% 12.10%
Tax rate 11.40% 11.70%
Debt/Equity ratio 0.44 0.44
Cost of debt 4.50% 6.10%
After-tax WACC 7.4% 10.1%
Selected WACC 8.7%